Received Dec 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z008197 | — |
No adverse events reported; HCP called to report TE where patient received product after it was improperly stored. No side effects or symptoms reported. No Additional AE/ No PQC. VARIVAX: z008197 exp: 04/30/2027 -10.5C for 1 hour 0 minutes 0 seconds no previous excursions; Information has been received from Business Partner/CRO on 04-Dec-2025. This spontaneous report was received from a/an Other health professional and refers to a(n) 4-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 25-Nov-2025, the patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Z008197, expiration date: 30-Apr-2027) 0.5 mL. On 25-Nov-2025, the patient started therapy with sterile diluent (Hollister-Stier STERILE DILUENT), (lot # and expiration date were not reported). The patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), for the treatment of prophylaxis. The patient started therapy with sterile diluent (Hollister-Stier STERILE DILUENT), for the treatment of prophylaxis. On 25-Nov-2025, the patient experienced HCP called to report TE where patient received product after it was improperly stored. No side effects or symptoms reported. No Additional AE/ No PQC. VARIVAX: z008197 exp: 04/30/2027 -10.5C for 1 hour 0 minutes 0 seconds no previous excursions. On an unknown date, the patient experienced No adverse events reported.
sterile diluent